BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36038346)

  • 1. [Study of the negative regulation of transforming growth factor beta type II receptor to inhibit the occurrence and development of liver fibrosis with miR-217].
    Guo YW; Pang PJ; Sun YK
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):752-757. PubMed ID: 36038346
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0009096/miR-370-3p modulates hepatic stellate cell proliferation and fibrosis during biliary atresia pathogenesis.
    Wu Z; Wang B; Chen S; Zuo T; Zhang W; Cheng Z; Fu J; Gong J
    PeerJ; 2024; 12():e17356. PubMed ID: 38766485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
    Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-122 inhibits hepatic stellate cell proliferation and activation in vitro and represses carbon tetrachloride-induced liver cirrhosis in mice.
    Ma J; Zhao Q; Chen M; Wang W; He B; Jiang Y; Li Y
    Ann Hepatol; 2022; 27(4):100700. PubMed ID: 35338010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin β4 suppresses CCl
    Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
    J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
    Li X; Li H; Zhang S; Zhang R; Li J; Wei Y; Yang C; Zhang F; Zhou H
    J Cell Mol Med; 2021 Dec; 25(24):11185-11197. PubMed ID: 34747105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-
    Qiu JL; Zhang GF; Chai YN; Han XY; Zheng HT; Li XF; Duan F; Chen LY
    J Pharmacol Exp Ther; 2022 Jun; 381(3):257-265. PubMed ID: 35398813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on promoting liver fibrosis injury by the targeted regulation of miR-202 for HGF to activate HSC.
    Niu X; Nong S; Gong J; Zhang X; Tang H; Zhou T; Li W
    Ir J Med Sci; 2020 Nov; 189(4):1295-1304. PubMed ID: 32270431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Igf2bp2 knockdown improves CCl
    Xu Z; He B; Jiang Y; Zhang M; Tian Y; Zhou N; Zhou Y; Chen M; Tang M; Gao J; Peng F
    Int Immunopharmacol; 2022 Sep; 110():108987. PubMed ID: 35820364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
    Fu J; Wu B; Zhong S; Deng W; Lin F
    Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
    Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
    J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway.
    Zheng J; Wu C; Xu Z; Xia P; Dong P; Chen B; Yu F
    Mol Cell Biochem; 2015 Jan; 398(1-2):1-9. PubMed ID: 25148875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1.
    Pan W; Wang Y; Zhao C
    Scand J Gastroenterol; 2023; 58(11):1335-1343. PubMed ID: 37313731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway.
    Wu Y; Li Z; Wang S; Xiu A; Zhang C
    Biomed Res Int; 2019; 2019():7932046. PubMed ID: 31828132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor.
    Wang LP; Dong JZ; Xiong LJ; Shi KQ; Zou ZL; Zhang SN; Cao ST; Lin Z; Chen YP
    Int J Clin Exp Pathol; 2014; 7(7):3537-47. PubMed ID: 25120732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
    Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
    Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.